AIG
ATXS

American International Group’s Astria Therapeutics ATXS Stock Holding History

American International Group’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,565
Closed -$346K – 246
2024
Q1 		$346K Buy
24,565
+8,122
+49% +$101K ﹤0.01% 1852
2023
Q4 		$126K Buy
16,443
+3,694
+29% +$20.4K ﹤0.01% 2426
2023
Q3 		$95.1K Buy
12,749
+453
+4% +$3.86K ﹤0.01% 2542
2023
Q2 		$102K Buy
+12,296
New +$142K ﹤0.01% 2561
2021
Q2 		– Sell
-1,967
Closed -$34 – 3118
2021
Q1 		$34 Buy
1,967
+5
+0.3% +$90 ﹤0.01% 3064
2020
Q4 		$25 Buy
1,962
+45
+2% +$802 ﹤0.01% 3062
2020
Q3 		$71K Buy
1,917
+78
+4% +$3.09K ﹤0.01% 2711
2020
Q2 		$71K Buy
+1,839
New +$65.5K ﹤0.01% 2727
2016
Q2 		– Sell
-44
Closed -$13K – 3142
2016
Q1 		$13K Buy
+44
New +$15.2K ﹤0.01% 4445

Other funds holding ATXS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

American International Group's ATXS Position: Q2 2024 in Review

American International Group sold out of Astria Therapeutics (ATXS) in Q2 2024, closing a stake of 24,565 shares — an estimated $346K sold.

American International Group first reported a position in ATXS in Q1 2016 and held it in 9 quarters. The position peaked at $346K in Q1 2024. 100 funds tracked by Wall St. Rank hold ATXS as of Q2 2024.

  • American International Group reported no remaining Astria Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 24,565 Astria Therapeutics shares in Q2 2024, an estimated $346K.
  • American International Group first reported a position in Astria Therapeutics in Q1 2016 and held it in 9 quarters.
  • American International Group's Astria Therapeutics position peaked at $346K in Q1 2024.
  • 100 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.